Atlas Trials

Prelude Therapeutics

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Prelude Therapeutics

RecordFirmDate
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms (NCT07469891)Prelude Therapeutics2026-04-29
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation (NCT06682806)Prelude Therapeutics2025-06-03
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation (NCT06560645)Prelude Therapeutics2024-11-04
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies (NCT05665530)Prelude Therapeutics2023-09-12
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation (NCT05639751)Prelude Therapeutics2023-05-02
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors (NCT05538572)Prelude Therapeutics2022-12-27
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies (NCT05107856)Prelude Therapeutics2022-03-22
A Study of PRT2527 in Participants With Advanced Solid Tumors (NCT05159518)Prelude Therapeutics2022-02-14
A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677)Prelude Therapeutics2021-08-11
A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT04543305)Prelude Therapeutics2020-09-28
A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas (NCT04089449)Prelude Therapeutics2019-11-06
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies (NCT03886831)Prelude Therapeutics2019-02-11

Track Prelude Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.